Scarica l'app Stockscreener
7.01
0.14%
-0.010
Precedente Chiudi:
$7.02
Aprire:
$6.91
Volume 24 ore:
50,547
Relative Volume:
0.10
Capitalizzazione di mercato:
$67.53M
Reddito:
-
Utile/perdita netta:
$-7.82M
Rapporto P/E:
-6.1143
EPS:
-1.1465
Flusso di cassa netto:
$-8.00M
1 W Prestazione:
-6.53%
1M Prestazione:
+34.55%
6M Prestazione:
+367.33%
1 anno Prestazione:
+238.65%
Intervallo 1D:
$6.91
$7.235
Intervallo di 1 settimana:
$6.91
$7.68
Portata 52W:
$0.72
$20.32
Edesa Biotech Inc Stock (EDSA) Company Profile
Nome
Edesa Biotech Inc
Settore
Industria
Telefono
(905) 475-1234
Indirizzo
100 SPY COURT, MARKHAM, ON
Compare EDSA vs VRTX, REGN, ARGX, ALNY, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
EDSA
Edesa Biotech Inc
|
7.01 | 67.53M | 0 | -7.82M | -8.00M | -1.1465 |
VRTX
Vertex Pharmaceuticals Inc
|
485.39 | 123.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
664.52 | 69.67B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.62 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
298.76 | 39.89B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
186.88 | 39.73B | 742.00K | -1.37B | -1.07B | -7.0731 |
Edesa Biotech Inc Borsa (EDSA) Ultime notizie
Why Did EDSA Stock Rally More Than 70% Today? - Stocktwits
EDSA Stock Rallied Over 50% Today: What’s Ahead For The Small-Cap Biotech? - Stocktwits
Enterprise value to EBIT forward of Edesa Biotech, Inc. – NASDAQ:EDSA - TradingView
Edesa Biotech Company Profile & Introduction - Moomoo
Edesa Biotech | 4: Statement of changes in beneficial ownership of securities-Officer Nijhawan Pardeep - Moomoo
Form S-3 EDESA BIOTECH For: 2 July By Investing.com - Investing.com India
Edesa Biotech (EDSA) CEO receives 3,378-share RSU grant - Stock Titan
Edesa Biotech (NASDAQ: EDSA) registers 729,241 shares for resale - Stock Titan
EDSA: Positive Exploratory Data in Patients with AKI - Yahoo Finance
Edesa Biotech Inc. (EDSA) Q1 2026 Earnings: Wider-Than-Expected Loss Weighs on SharesShare Repurchase Impact - dars.gov.et
Brookline Capital Initiates Edesa Biotech(EDSA.US) With Buy Rating, Announces Target Price $21 - Moomoo
Brookline initiates Edesa Biotech stock with buy on pipeline By Investing.com - Investing.com Nigeria
Brookline initiates Edesa Biotech stock with buy on pipeline - Investing.com
Edesa Biotech Inc (EDSA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Edesa Biotech, Inc. Actuals & Estimates (NASDAQ:EDSA) - TradingView
EDSA Should I Buy - Intellectia AI
Price to book forward of Edesa Biotech, Inc. – NASDAQ:EDSA - TradingView
EDSA Forecast — Price Target — Prediction for 2027 - TradingView
Edesa Biotech Inc (EDSA) Valuation: PE, PB & Fair Value Analysis - TradingKey
Edesa Biotech Inc (EDSA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Edesa Biotech Inc (EDSA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
CEO, Company Secretary & Director of Edesa Biotech Pardeep Nijhawan Buys 28% More Shares - simplywall.st
Edesa Biotech (EDSA) joint filing reports 5.4% stake by Millennium group - Stock Titan
Edesa Biotech announces $3.5M PIPE financing - MSN
Edesa Biotech Inc (EDSA) Institutional Confidence - TradingKey
Edesa Biotech Inc (EDSA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Edesa Biotech Inc (EDSA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Edesa Biotech Inc (EDSA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Edesa Biotech Inc (EDSA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Nijhawan lifts Edesa Biotech (EDSA) beneficial ownership stake to 19.99% - Stock Titan
Edesa Biotech (EDSA) CEO invests $799,995.50 in private share purchase - Stock Titan
Edesa Biotech Inc. Q1 2026 Earnings: Wider-than-Expected Loss as Pre-Commercial R&D Costs PersistMargin Compression Risk - newsline.com
Edesa Biotech Advances on Promising Drug Trial Results - timothysykes.com
Edesa Biotech Gains Ground with Positive Clinical and Financial News - timothysykes.com
EDSA Q1 2026 Earnings: Misses EPS Estimates Amid Pre-Revenue Stage, Stock Rises 2.65%Mid-Term Outlook - newsline.com
Edesa Biotech Inc. (EDSA) Posts Strong 8.45% Gain, Testing Key ResistanceValue Factor - newsline.com
Edesa Biotech secures $3.5 million private placement financing By Investing.com - Investing.com Australia
Edesa Biotech announces $3.5M private placement - TipRanks
Edesa Biotech Announces Insider-Led PIPE Financing Agreement - TipRanks
Edesa Biotech secures $3.5 million private placement financing - Investing.com
Edesa Biotech Raises $3.5 Million in Private Placement, Issues 729,241 Shares - TradingView
Edesa Biotech (Nasdaq: EDSA) sets $3.5M PIPE led by CEO - Stock Titan
Edesa Biotech, Inc. Announces $3.5 Million PIPE Financing to Advance Clinical Programs - Quiver Quantitative
Edesa Biotech Announces $3.5 Million Private Placement of - GlobeNewswire
Edesa Biotech Inc Azioni (EDSA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.64%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):